#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicle centre lymphoma follicular grade I, II – III T-cell type acute leukaemia Acute respiratory distress syndrome Drug eruption Congenital aplastic anaemia Glycogen storage disease type V Lip and/or oral cavity cancer Leukodystrophy Precursor T-lymphoblastic lymphoma/leukaemia recurrent Thrombotic microangiopathy Rett syndrome Haemophilia Retinoblastoma Follicular lymphoma stage I Inborn error of metabolism More trials…

    Learn about Rare Diseases

    Basal cell naevus syndrome – Life with Disease Antithrombin III deficiency – Basic Information Breast angiosarcoma – Basic Information Methylmalonic acidaemia – Diagnostics Hairy cell leukaemia – Trials in Disease Thrombotic thrombocytopenic purpura – Diagnostics Idiopathic inflammatory myopathy – Basic Information Lymphangioma – Trials in Disease Haemophilia A with anti factor VIII – Basic Information Marfan’s syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ganciclovir Alectinib Hydrochloride Rbl007.2 Xenon (129Xe) Atorvastatin Brepocitinib Tosilate Abc-16F-116 Valine Dabigatran Etexilate Vinblastine Sulfate Omp66 Perflubutane Lactose Fluorouracil TEV-53408 Mirvetuximab Soravtansine FRUQUINTINIB Nelivaptan Pf-06480605 Clenbuterol Hydrochloride More therapies…

    Learn about Your Condition

    Infertility male Urinary incontinence Erythema Turner's syndrome Melanoma recurrent Cutaneous lupus erythematosus Hidradenitis Mucopolysaccharidosis I Endolymphatic hydrops Langerhans cell sarcoma Ectopic pregnancy Vulvovaginal pruritus Ehlers-Danlos syndrome Ligament operation Round cell liposarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acute myeloid leukaemia

  • Study on the Safety and Effectiveness of Adding Hydroxycarbamide to Standard Treatment with Cytarabine and Daunorubicin for Adults with Newly Diagnosed Acute Myeloid Leukemia

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Hydroxycarbamide
    • Cytarabine
    • Daunorubicin
    Sweden

  • Study on the Safety and Effectiveness of Quizartinib for Children and Young Adults with Acute Myeloid Leukemia (AML)

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia recurrent
    • Fms-like tyrosine kinase 3 positive
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Quizartinib Dihydrochloride
    Belgium Denmark France Italy The Netherlands Spain +1

  • Study of Tamibarotene, Venetoclax, and Azacitidine for Adults with RARA-positive Acute Myeloid Leukemia Not Eligible for Standard Therapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Tamibarotene
    • Azacitidine
    • Venetoclax
    France

  • Study on Midostaurin and Chemotherapy for Children with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Midostaurin
    • Fludarabine
    • Idarubicin
    Austria Czechia Germany Italy Poland Slovenia

  • Study of Gilteritinib and Chemotherapy for Children, Adolescents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia with FLT3 Mutation

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Gilteritinib
    • Filgrastim
    • Fludarabine Phosphate
    France Germany Italy Spain

  • Study on S65487 and Azacitidine for Adults with Untreated Acute Myeloid Leukemia Not Suitable for Intensive Treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • 4-{[(3S)-2-(4-Chloro-2-{4-[(5-Cyano-1,2-Dimethyl-1H-Pyrrol-3-Yl)(4-Hydroxyphenyl)Carbamoyl]-1,5-Dimethyl-1H-Pyrrol-2-Yl}Benzoyl)-1,2,3,4-Tetrahydroisoquinolin-3-Yl]Methyl}Morpholin-4-Ium Hydrogen Sulfate
    • Posaconazole
    • Azacitidine
    France Spain
Previous Page
1 … 15 16 17 18 19 … 21
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!